CyberSAR Articles

CyberAIDD assisted analysis of drug discovery article Titled “Discovery of 6,7-Dihydropyrazolo[1,5-a] pyrazin-4(5H)-one Derivatives as mGluR2 Negative Allosteric Modulators with In Vivo Activity in a Rodent’s

CyberAIDD assisted analysis of Drug Discovery article titled Discovery of JNJ-748566665, A Novel isoquinolone DHODH inhibitor for treatment of AML developed by Johnson & Johnson

CyberAIDD assisted analysis of Drug Discovery article titled Discovery of JNJ-748566665, A Novel isoquinolone DHODH inhibitor for treatment of AML developed by Johnson & Johnson

CyberAnalysis of the molecular design and optimization of the SIK2/3 inhibitor GLPG3970 developed by Galapagos

Cyber AIDD Screening weekly Report- Androgen Receptor Degraders for Prostrate Cancer.

Cyber Weekly Report_ G-5758 a highly potent and selective oral IRE1α kinase inhibitor developed by Genentech.

Cyber-AIDD Analysis of PARK7/DJ-1 Inhibitors, probes and PROTACs Discovery and optimization

CyberAIDD Analysis CBPD-268^J an orally available CBPp300 PROTAC degrader

CyberAIDD Platform an alyzes G-protein-coupled estrogen receptor-mediated 2, 4, 5- trimethylpyridine-3-ols

× How can I help you?